News

Statement by the Board of Directors of Meda in relation to the public offer by Mylan

Mylan N.V., a leading global pharmaceutical company whose ordinary shares (“Mylan Shares”) are traded on the NASDAQ Global Select Market and the Tel Aviv Stock Exchange under the symbol “MYL”, has today announced a public offer to the shareholders of Meda to transfer all of their shares in Meda to Mylan for a consideration consisting of a combination of cash and Mylan Shares (the “Offer”). Mylan is offering each Meda shareholder.

Read more

Armolipid PLUS

Armolipid PLUS was launched in January 2016

Read more

Archive

Categories

Popular topics

This website is intended for people seeking information on Meda Health Sales Ireland. The product information provided in this site is intended for residents of Ireland only.
We also have country specific marketing websites. Links to these are under Meda Worldwide at the top of the page.